Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opti-Q: Levofloxacin for MDR-TB
NCT01918397Phase 2Completed
- Sponsor
- Boston University
- Start
- Jan 2015
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of levofloxacin in Tuberculosis (TB), sponsored by Boston University. Started Jan 2015; status: completed.
02
Drugs
levofloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01918397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918397.